Inhalable Ebola vaccine in the works; doctors find possible cancer ‘master switch’

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Scientists in Galveston, Texas, are testing an inhalable version of an Ebola vaccine on primates. Their tests proved that just one dose was strong enough to protect monkeys exposed to 1,000 times the fatal dosage of the disease. Researchers say they will now look at expanding the vaccine to human test subjects.

Although they remain cautious because the last Ebola vaccine that was successful in primates, failed when given to people. If this vaccine does work on humans, doctors would not have to distribute it and could protect people from the highly contagious disease, which would be extremely beneficial in countries that lack a strong healthcare system.

There was also a breakthrough in cancer research.

Scientists at Thomas Jefferson University in Philadelphia have found what they are calling a master switch that causes cancer to spread. The first time the molecule as been discovered. Researchers say its the crucial molecule that enables the disease to spread and turn deadly.